PubMed ID: 22017839 Author(s): Cordeiro MF, Levin LA. Clinical evidence for neuroprotection in glaucoma. Am J Ophthalmol. 2011 Nov;152(5):715-6. doi: 10.1016/j.ajo.2011.06.015. PMID 22017839 Journal: American Journal Of Ophthalmology, Volume 152, Issue 5, Nov 2011
Publications
Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
PubMed ID: 21862954 Author(s): Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC; PKC-DRS and PKC-DRS2 Study Groups. Oral protein kinase c β inhibition using ruboxistaurin: …
Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
PubMed ID: 21659941 Author(s): Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina. 2011 Nov;31(10):2032-6. doi: 10.1097/IAE.0b013e31820f4b4f. PMID 21659941 Journal: Retina (Philadelphia, Pa.), Volume 31, Issue 10, …
An extraordinary orbital foreign body.
PubMed ID: 21464792 Author(s): Naik MN, Das S, Oluyemi F, Honavar SG. An extraordinary orbital foreign body. Ophthalmic Plast Reconstr Surg. 2011 Nov-Dec;27(6):e149-52. doi: 10.1097/IOP.0b013e3182078e88. PMID 21464792 Journal: Ophthalmic Plastic And Reconstructive Surgery, Volume 27, …
Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.
PubMed ID: 21839131 Author(s): Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine. Vaccine. 2011 Oct 13;29(44):7696-703. doi: 10.1016/j.vaccine.2011.07.133. Epub 2011 Aug 10. PMID 21839131 …
Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.
PubMed ID: 21972262 Author(s): Weinreb RN, Kaufman PL. Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol …
Modifiable determinants of hearing impairment in adults.
PubMed ID: 21871479 Author(s): Zhan W, Cruickshanks KJ, Klein BE, Klein R, Huang GH, Pankow JS, Gangnon RE, Tweed TS. Modifiable determinants of hearing impairment in adults. Prev Med. 2011 Oct;53(4-5):338-42. doi: 10.1016/j.ypmed.2011.08.012. Epub 2011 …
The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.
PubMed ID: 21492158 Author(s): Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, Saaddine JB; Vision Cost-Effectiveness Study Group. The cost-effectiveness of three screening alternatives for people with diabetes with no or …
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
PubMed ID: 21840602 Author(s): Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide …